Literature DB >> 12922131

Unintended events following immunization with MMR: a systematic review.

Tom Jefferson1, Deirdre Price, Vittorio Demicheli, Elvira Bianco.   

Abstract

Public debate over the safety of the trivalent measles, mumps and rubella (MMR) vaccine and the drop in vaccination rates in several countries persists despite its almost universal use and accepted effectiveness. We carried out a systematic review to assess the evidence of unintended effects (beneficial or harmful) associated with MMR and the applicability of systematic reviewing methods to the field of safety evaluation. Eligible studies were comparative prospective or retrospective on healthy individuals up to 15 years of age, carried out or published by 2003. We identified 120 articles satisfying our inclusion criteria and included 22. MMR is associated with a lower incidence of upper respiratory tract infections, a higher incidence of irritability, similar incidence of other adverse effects compared to placebo and is likely to be associated with benign thrombocytopenic purpura (TP), parotitis, joint and limb complaints and aseptic meningitis (mumps Urabe strain-containing MMR). Exposure to MMR is unlikely to be associated with Crohn's disease, ulcerative colitis, autism or aseptic meningitis (mumps Jeryl-Lynn strain-containing MMR). The design and reporting of safety outcomes in MMR vaccine studies, both pre- and post-marketing, are largely inadequate. The evidence of adverse events following immunization with MMR cannot be separated from its role in preventing the target diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12922131     DOI: 10.1016/s0264-410x(03)00271-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Balancing benefits and harms in health care: observational data on harm are already included in systematic reviews.

Authors:  Tom Jefferson; Vittorio Demicheli
Journal:  BMJ       Date:  2003-09-27

2.  Evidence-based clinical guidelines for immigrants and refugees.

Authors:  Kevin Pottie; Christina Greenaway; John Feightner; Vivian Welch; Helena Swinkels; Meb Rashid; Lavanya Narasiah; Laurence J Kirmayer; Erin Ueffing; Noni E MacDonald; Ghayda Hassan; Mary McNally; Kamran Khan; Ralf Buhrmann; Sheila Dunn; Arunmozhi Dominic; Anne E McCarthy; Anita J Gagnon; Cécile Rousseau; Peter Tugwell
Journal:  CMAJ       Date:  2010-06-07       Impact factor: 8.262

3.  Temporal data mining for adverse events following immunization in nationwide Danish healthcare databases.

Authors:  Henrik Svanström; Torbjörn Callréus; Anders Hviid
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

Review 4.  Models of foot-and-mouth disease.

Authors:  Matt J Keeling
Journal:  Proc Biol Sci       Date:  2005-06-22       Impact factor: 5.349

Review 5.  Vaccination in elite athletes.

Authors:  Barbara C Gärtner; Tim Meyer
Journal:  Sports Med       Date:  2014-10       Impact factor: 11.136

6.  Familial thrombocytopenia flare-up following the first dose of mRNA-1273 Covid-19 vaccine.

Authors:  Sudhamshi Toom; Brian Wolf; Akshay Avula; Stephen Peeke; Kevin Becker
Journal:  Am J Hematol       Date:  2021-03-01       Impact factor: 13.265

7.  Epidemiological study of adverse events following immunization in under 5 year children.

Authors:  Vikrant S Pagar; Sushant S Chavan; Sarika P Patil; Anant Borde; Amol D Kinge; Naveen Khargekar
Journal:  J Family Med Prim Care       Date:  2021-07-30

Review 8.  Systematic reviews of adverse effects: framework for a structured approach.

Authors:  Yoon K Loke; Deirdre Price; Andrew Herxheimer
Journal:  BMC Med Res Methodol       Date:  2007-07-05       Impact factor: 4.615

9.  Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews.

Authors:  April V P Clyburne-Sherin; Pravheen Thurairajah; Mufiza Z Kapadia; Margaret Sampson; Winnie W Y Chan; Martin Offringa
Journal:  Trials       Date:  2015-09-18       Impact factor: 2.279

10.  Postinfluenza Vaccination Idiopathic Thrombocytopenic Purpura in Three Elderly Patients.

Authors:  Joji Nagasaki; Masahiro Manabe; Kentaro Ido; Hiroyoshi Ichihara; Yasutaka Aoyama; Tadanobu Ohta; Yoshio Furukawa; Atsuko Mugitani
Journal:  Case Rep Hematol       Date:  2016-02-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.